Business Context and Reporting Period
This Form 6-K filing is submitted by Galapagos NV (not Lakefront Biotherapeutics NV as indicated in metadata) for the month of November 2016. The filing, dated November 23, 2016, serves to incorporate a press release issued on November 22, 2016, by reference. The registrant is a foreign private issuer based in Mechelen, Belgium, filing under Form 20-F.
Financial Metrics
The filing text does not provide specific financial data. No revenue, profit, cash flow, margins, debt, or liquidity figures are disclosed in this document. The filing solely references an attached press release (Exhibit 99.1) without summarizing its financial content.
Material Changes
The filing does not detail material changes versus prior periods. It only confirms the issuance of a press release on November 22, 2016, which is incorporated by reference into the company's Registration Statements on Forms F-3 and S-8.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or unusual items. These details are presumed to be contained within the attached press release (Exhibit 99.1), the content of which is not provided in the input text.
Key Facts for Investor Verification
- Verify the actual content of the press release dated November 22, 2016 (Exhibit 99.1), as this filing contains no substantive operational or financial details.
- Confirm the registrant name is Galapagos NV, not Lakefront Biotherapeutics NV.
- Check the referenced Registration Statements (File Nos. 333-211765, 333-204567, 333-208697, and 333-211834) for further context on the incorporated information.